Literature DB >> 25568400

How do you know it is true? Integrity in research and publications: AOA critical issues.

Joseph A Buckwalter1, Vernon T Tolo2, Regis J O'Keefe3.   

Abstract

High-quality medical care is the result of clinical decisions based upon scientific principles garnered from basic, translational, and clinical research. Information regarding the natural history of diseases and their responses to various treatments is introduced into the medical literature through the approximately one million PubMed journal articles published each year. Pharmaceutical and device companies, universities, departments, and researchers all stand to gain from research publication. Basic and translational research is highly competitive. Success in obtaining research funding and career advancement requires scientific publication in the medical literature. Clinical research findings can lead to changes in the pattern of orthopaedic practice and have implications for the utilization of pharmaceuticals and orthopaedic devices. Research findings can be biased by ownership of patents and materials, funding sources, and consulting arrangements. The current high-stakes research environment has been characterized by an increase in plagiarism, falsification or manipulation of data, selected presentation of results, research bias, and inappropriate statistical analyses. It is the responsibility of the orthopaedic community to work collaboratively with industry, universities, departments, and medical researchers and educators to ensure the integrity of the content of the orthopaedic literature and to enable the incorporation of best practices in the care of orthopaedic patients.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 25568400      PMCID: PMC4279030          DOI: 10.2106/JBJS.N.00245

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  39 in total

Review 1.  Conflict of interest in the assessment of thromboprophylaxis after total joint arthroplasty: a systematic review.

Authors:  Young-Kyun Lee; Chin Youb Chung; Kyung-Hoi Koo; Kyoung Min Lee; Hyung-Min Ji; Moon Seok Park
Journal:  J Bone Joint Surg Am       Date:  2012-01-04       Impact factor: 5.284

2.  Journals step up plagiarism policing.

Authors:  Declan Butler
Journal:  Nature       Date:  2010-07-08       Impact factor: 49.962

3.  How the case against the MMR vaccine was fixed.

Authors:  Brian Deer
Journal:  BMJ       Date:  2011-01-05

4.  The Scott Reuben saga: one last retraction.

Authors:  Paul F White; Carl E Rosow; Steven L Shafer
Journal:  Anesth Analg       Date:  2011-03       Impact factor: 5.108

5.  Secrets of the MMR scare . How the vaccine crisis was meant to make money.

Authors:  Brian Deer
Journal:  BMJ       Date:  2011-01-11

6.  Pharmaceutical fraud and abuse in the United States, 1996-2010.

Authors:  Zaina P Qureshi; Oliver Sartor; Sudha Xirasagar; Ying Liu; Charles L Bennett
Journal:  Arch Intern Med       Date:  2011-09-12

7.  Alterations in expression of cartilage-specific genes for aggrecan and collagen type II in osteoarthritis.

Authors:  B A Jalbă; C S Jalbă; Anca Daniela Vlădoi; F Gherghina; E Stefan; M Cruce
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

8.  A model for dissemination and independent analysis of industry data.

Authors:  Harlan M Krumholz; Joseph S Ross
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

9.  A historic moment for open science: the Yale University Open Data Access project and medtronic.

Authors:  Harlan M Krumholz; Joseph S Ross; Cary P Gross; Ezekiel J Emanuel; Beth Hodshon; Jessica D Ritchie; Jeffrey B Low; Richard Lehman
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

10.  The development of open access journal publishing from 1993 to 2009.

Authors:  Mikael Laakso; Patrik Welling; Helena Bukvova; Linus Nyman; Bo-Christer Björk; Turid Hedlund
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.